| 000 | 01623 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250511174831.0 | ||
| 264 | 0 | _c19930107 | |
| 008 | 199301s 0 0 eng d | ||
| 022 | _a0160-2446 | ||
| 024 | 7 |
_a10.1097/00005344-199210000-00016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurke, S E | |
| 245 | 0 | 0 |
_aReduction of canine myocardial infarct size by CI-959, an inhibitor of inflammatory cell activation. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cOct 1992 |
||
| 300 |
_a619-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacokinetics |
| 650 | 0 | 4 |
_aCoronary Circulation _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 |
_aFree Radicals _xmetabolism |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Infarction _xdrug therapy |
| 650 | 0 | 4 |
_aMyocardium _xpathology |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aPhagocytosis _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacokinetics |
| 650 | 0 | 4 |
_aThiophenes _xpharmacokinetics |
| 650 | 0 | 4 |
_aVentricular Fibrillation _xphysiopathology |
| 700 | 1 | _aWright, C D | |
| 700 | 1 | _aPotoczak, R E | |
| 700 | 1 | _aBoucher, D M | |
| 700 | 1 | _aDodd, G D | |
| 700 | 1 | _aTaylor, D G | |
| 700 | 1 | _aKaplan, H R | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 20 _gno. 4 _gp. 619-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00005344-199210000-00016 _zAvailable from publisher's website |
| 999 |
_c1287249 _d1287249 |
||